Expression and the clinical significance of Wnt10a and Wnt10b in endometrial cancer are associated with the Wnt/β-catenin pathway

Chen,Hongman; Wang,Yingmei; Xue,Fengxia

doi:10.3892/or.2012.2126

Expression and the clinical significance of Wnt10a and Wnt10b in endometrial cancer are associated with the Wnt/β-catenin pathway

Authors:
- Hongman Chen
- Yingmei Wang
- Fengxia Xue
View Affiliations

Affiliations: Department of Gynecology and Obstetrics, Tianjin Medical University General Hospital, Tianjin 300052, P.R. China
Published online on: November 7, 2012 https://doi.org/10.3892/or.2012.2126
Pages: 507-514

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

To determine the role played by the Wnt/β-catenin signaling pathway in the development of endometrial cancer (EC), we examined the expression of Wnt10a and Wnt10b in EC tissues and the correlation between their expression. Furthermore, the associations between these two proteins and the clinicopathological characteristics and prognosis of EC were also evaluated. In our search of alternative mechanisms, we investigated the impact of Wnt10b on proliferation and apoptosis of EC cells. Western blotting, 3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and flow cytometry were used to evaluate the expression of Wnt10b and some key proteins of the Wnt/β-catenin pathway, proliferation and apoptosis in EC. Our results showed that Wnt10b expression in EC tissues was significantly higher compared to that in hyperplastic and normal samples. The expression of Wnt10a in endometrioid cancer tissues was higher compared to that in other types of cancerous samples. The difference in Wnt10b levels was significant among subgroups for histological type, grade of differentiation, FIGO phase and lymphovascular metastasis. Furthermore, no correlation was observed between the expression of Wnt10a and Wnt10b. In the follow-up, Wnt10b gene expression was frequently upregulated in EC and associated with better prognostic clinicopathological markers in EC patients. Collectively, the in vitro data showed that the upregulated expression of Wnt10b in Ishikawa cells promoted proliferation and inhibited apoptosis through β-catenin and c-myc activation and adenomatous polyposis coli (APC) inhibition, which suggests that Wnt10b activates EC via the Wnt/β-catenin pathway. These results suggest that Wnt10b likely plays an important role in the development of EC. Furthermore, these results identify a role for Wnt10b in EC cells through promoting proliferation and inhibiting apoptosis, primarily through the activation of the Wnt/β-catenin pathway. The role played by Wnt10a in EC, however, still requires further investigation.

View Figures

View References

1	Siegel R, Ward E, Brawley O and Jemal A: Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 61:212–236. 2011. View Article : Google Scholar : PubMed/NCBI
2	Yang D and Han L: Year 1969–2003 study on evolution of endometrial cancer. FuDan Univ J Med Sci. 32:479–483. 2005.
3	Bokhman JV: Two pathogenetic types of endometrial carcinoma. Gynecol Oncol. 15:10–17. 1983. View Article : Google Scholar : PubMed/NCBI
4	Fleming GF: Systemic chemotherapy for uterine carcinoma: metastatic and adjuvant. J Clin Oncol. 25:2983–2990. 2007. View Article : Google Scholar : PubMed/NCBI
5	Nusse R: Wnt signaling in disease and in development. Cell Res. 15:28–32. 2005. View Article : Google Scholar : PubMed/NCBI
6	Katoh M: WNT and FGF gene clusters (Review). Int J Oncol. 21:1269–1273. 2002.PubMed/NCBI
7	Wend P, Wend K, Krum SA and Miranda-Carboni GA: The role of WNT10B in physiology and disease. Acta Physiol (Oxf). 204:34–51. 2012. View Article : Google Scholar : PubMed/NCBI
8	Modder UI, Oursler MJ, Khosla S and Monroe DG: Wnt10b activates the Wnt, notch and NFκB pathways in U2OS osteosarcoma cells. J Cell Biochem. 112:1392–1402. 2011.PubMed/NCBI
9	White BD, Chien AJ and Dawson DW: Dysregulation of Wnt/β-catenin signaling in gastrointestinal cancers. Gastroenterology. 142:219–232. 2012.
10	Robinson DR, Zylstra CR and Williams BO: Wnt signaling and prostate cancer. Curr Drug Targets. 9:571–580. 2008. View Article : Google Scholar
11	Mukheriee N, Bhattacharya N, Alam N, et al: Subtype-specific alteration of the Wnt signaling pathway in breast cancer: clinical and prognostic significance. Cancer Sci. 103:210–220. 2012. View Article : Google Scholar : PubMed/NCBI
12	Gatcliffe TA, Monk BJ, Planutis K and Holcombe RF: Wnt signaling in ovarian tumorigenesis. Int J Gynecol Cancer. 18:954–962. 2008. View Article : Google Scholar : PubMed/NCBI
13	Carmon KS and Loose DS: Development of bioassay for detection of Wnt-binding affinities for individual frizzled receptors. Anal Biochem. 401:288–294. 2010. View Article : Google Scholar : PubMed/NCBI
14	Kirikoshi H, Sekihara H and Katoh M: WNT10A and WNT6, clustered in human chromosome 2q35 region with head-to-tail manner, are strongly co-expressed in SW480 cells. Biochem Biophy Res Commun. 283:798–805. 2001. View Article : Google Scholar : PubMed/NCBI
15	Benhaj K, Akcali KC and Oztuk M: Redundant expression of canonical Wnt ligands in human breast cancer cell lines. Oncol Rep. 15:701–707. 2006.PubMed/NCBI
16	Saegusa M, Hashimura M, Yoshida T and Okayasu I: Beta-catenin mutations and aberrant nuclear expression during endometrial tumorigenesis. Br J Cancer. 84:209–217. 2001. View Article : Google Scholar : PubMed/NCBI
17	Wang Y, Yang D, Cogdell D, Hu L, Xue F, Broaddus R and Zhang W: Genomic characterization of gene copy-number aberrations in endometrial carcinoma cell lines derived from endometrioid-type endometrial adenocarcinoma. Technol Cancer Res Treat. 9:179–189. 2010. View Article : Google Scholar : PubMed/NCBI
18	Dellinger TH, Planutis K, Tewari KS and Holcombe RF: Role of canonical Wnt signaling in endometrial carcinogenesis. Expert Rev Anticancer Ther. 12:51–62. 2012. View Article : Google Scholar : PubMed/NCBI
19	Kirikoshi H, Inoue S, Sekihara H and Katoh M: Expression of WNT10A in human cancer. Int J Oncol. 19:997–1001. 2001.PubMed/NCBI
20	Brennan KR and Brown AM: Wnt proteins in mammary development and cancer. J Mammary Gland Biol Neoplasia. 9:119–131. 2004. View Article : Google Scholar : PubMed/NCBI
21	Barbolina MV, Burkhalter RJ and Stack MS: Diverse mechanisms for activation of Wnt signaling in the ovarian tumour microenviroment. Biochem J. 437:1–12. 2011. View Article : Google Scholar : PubMed/NCBI
22	Kirikoshi H, Sekihara H and Katoh M: Up-regulation of WNT10A by tumor necrosis factor alpha and Helicobacter pylori in gastric cancer. Int J Oncol. 19:533–536. 2001.PubMed/NCBI
23	Milovanovic T, Planutis K, Nquyen A, Marsh JL, Lin F, Hope C and Holcombe RF: Expression of Wnt genes and frizzled 1 and 2 receptors in normal breast epithelium and infiltrating breast carcinoma. Int J Oncol. 25:1337–1342. 2004.PubMed/NCBI
24	Kharaishvili G, Simkova D, Makharoblidze E, et al: Wnt signaling in prostate development and carcinogenesis. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 155:11–18. 2011. View Article : Google Scholar : PubMed/NCBI
25	Nishida M: The Ishikawa cells from birth to the present. Hum Cell. 15:104–117. 2002. View Article : Google Scholar : PubMed/NCBI
26	Lustig B and Behrens J: The Wnt signaling pathway and its role in tumor development. J Cancer Res Clin Oncol. 129:199–221. 2003.PubMed/NCBI
27	Fernandez-Cobo M, Zammarchi F, Mandeli J, Holland JF and Pogo BG: Expression of Wnt5A and Wnt10b in non-immortalized breast cancer cells. Oncol Rep. 17:903–907. 2007.PubMed/NCBI
28	Scholten AN, Creutzberg CL, van den Broek LJ, Noordijk EM and Smit VT: Nuclear beta-catenin is a molecular feature of type 1 endometrial carcinoma. J Pathol. 201:460–465. 2003. View Article : Google Scholar : PubMed/NCBI
29	Polakis P: Wnt signaling and cancer. Genes Dev. 14:1837–1851. 2000.
30	Wang Y, van der Zee, Fodde R and Blok LJ: Wnt/B-catenin and sex hormone signaling in endometrial homeostasis and cancer. Oncotarget. 1:674–684. 2010.PubMed/NCBI
31	Kirikoshi H and Katoh M: Expression and regulation of WNT10B in human cancer: up-regulation of WNT10B in MCF-7 cells by beta-estradiol and down-regulation of WNT10B in NT2 cells by retinoic acid. Int J Mol Med. 10:507–511. 2002.PubMed/NCBI
32	Lu Lu KH, Wu W, Dave B, Slomovitz BM, Burke TW, Munsell MF, Broaddus RR and Walker CL: Loss of tuberous sclerosis complex-2 function and activation of mammalian target of rapamycin signaling in endometrial carcinoma. Clin Cancer Res. 14:2543–2550. 2008.PubMed/NCBI